峆一药业
(920478)
| 流通市值：7.17亿 | | | 总市值：11.79亿 |
| 流通股本：6700.42万 | | | 总股本：1.10亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 76,006,054.25 | 46,166,565.25 | 287,684,655.66 | 210,767,634.24 |
| 营业收入 | 76,006,054.25 | 46,166,565.25 | 287,684,655.66 | 210,767,634.24 |
| 二、营业总成本 | 83,293,516.92 | 45,849,960.29 | 235,640,884.72 | 165,268,778.91 |
| 营业成本 | 53,846,054.98 | 31,791,767.93 | 180,868,193.25 | 123,858,732.15 |
| 税金及附加 | 1,913,668.88 | 1,056,077.49 | 3,377,466.61 | 2,528,968.27 |
| 销售费用 | 1,438,839.04 | 720,056.5 | 2,248,239.72 | 2,106,024.8 |
| 管理费用 | 16,635,095.45 | 6,751,314.03 | 29,637,294.49 | 21,993,272.26 |
| 研发费用 | 8,315,477.44 | 5,148,745.76 | 20,303,897.58 | 15,717,318.93 |
| 财务费用 | 1,144,381.13 | 381,998.58 | -794,206.93 | -935,537.5 |
| 其中:利息费用 | 396,751.99 | - | 76,679.24 | 176,014.68 |
| 其中:利息收入 | 234,415.84 | - | 432,617.81 | 340,883.97 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -182,999.7 | -127,837.05 | -650,284.7 | -836,134.77 |
| 加:投资收益 | 1,331,684.22 | 533,528.88 | 2,637,269.58 | 2,591,621.14 |
| 资产减值损失(新) | - | 946,025.18 | -3,087,468.69 | 161,456.34 |
| 信用减值损失(新) | 675,737.01 | -506,539.03 | 492,807.12 | 998,082.2 |
| 其他收益 | 2,725,590.5 | 1,157,281.1 | 2,531,621.36 | 2,143,328.28 |
| 四、营业利润 | -2,737,450.64 | 2,319,064.04 | 53,967,715.61 | 50,557,208.52 |
| 加:营业外收入 | 40,705.54 | 30,251.1 | 6,725.26 | 2,500.72 |
| 减:营业外支出 | 3,018,324.49 | 12,769.19 | 300,081.45 | 64,989.55 |
| 五、利润总额 | -5,715,069.59 | 2,336,545.95 | 53,674,359.42 | 50,494,719.69 |
| 减:所得税费用 | 440,124.81 | 669,530.83 | 9,028,445.82 | 7,338,715.18 |
| 六、净利润 | -6,155,194.4 | 1,667,015.12 | 44,645,913.6 | 43,156,004.51 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -6,155,194.4 | 1,667,015.12 | 44,645,913.6 | 43,156,004.51 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -2,531,077.58 | 3,221,500 | 50,164,943.14 | 45,946,360.24 |
| 少数股东损益 | -3,624,116.82 | -1,554,484.88 | -5,519,029.54 | -2,790,355.73 |
| 扣除非经常损益后的净利润 | -3,168,146.13 | 2,163,022.4 | 47,309,088.09 | 43,479,197.54 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.02 | 0.04 | 0.64 | 0.58 |
| (二)稀释每股收益 | - | - | 0.64 | - |
| 九、综合收益总额 | -6,155,194.4 | 1,667,015.12 | 44,645,913.6 | 43,156,004.51 |
| 归属于母公司股东的综合收益总额 | -2,531,077.58 | 3,221,500 | 50,164,943.14 | 45,946,360.24 |
| 归属于少数股东的综合收益总额 | -3,624,116.82 | -1,554,484.88 | -5,519,029.54 | -2,790,355.73 |
| 公告日期 | 2026-08-21 | 2026-04-28 | 2026-04-16 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |